4.5 Article

Machine learning-based decision tree classifier for the diagnosis of progressive supranuclear palsy and corticobasal degeneration

期刊

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
卷 47, 期 7, 页码 931-941

出版社

WILEY
DOI: 10.1111/nan.12710

关键词

corticobasal degeneration; corticobasal syndrome; decision tree classifier; hierarchical cluster analysis; Machine learning; progressive supranuclear palsy

资金

  1. Karin & Sten Mortstedt CBD Solutions Research Grant
  2. CurePSP
  3. Rainwater Charitable Trust
  4. Jaye F. and Betty F. Dyer Foundation
  5. NINDS Tau Center without Walls [U54-NS100693]

向作者/读者索取更多资源

By analyzing tau pathology scores in different brain regions of a large number of PSP and CBD cases and establishing a decision tree classifier, it was found that the severity of tau lesions in certain brain regions is crucial for distinguishing between PSP and CBD.
Aims This study aimed to clarify the different topographical distribution of tau pathology between progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) and establish a machine learning-based decision tree classifier. Methods Paraffin-embedded sections of the temporal cortex, motor cortex, caudate nucleus, globus pallidus, subthalamic nucleus, substantia nigra, red nucleus, and midbrain tectum from 1020 PSP and 199 CBD cases were assessed by phospho-tau immunohistochemistry. The severity of tau lesions (i.e., neurofibrillary tangle, coiled body, tufted astrocyte or astrocytic plaque, and tau threads) was semi-quantitatively scored in each region. Hierarchical cluster analysis was performed using tau pathology scores. A decision tree classifier was made with tau pathology scores using 914 cases. Cross-validation was done using 305 cases. An additional ten cases were used for a validation study. Results Cluster analysis displayed two distinct clusters; the first cluster included only CBD, and the other cluster included all PSP and six CBD cases. We built a decision tree, which used only seven decision nodes. The scores of tau threads in the caudate nucleus were the most decisive factor for predicting CBD. In a cross-validation, 302 out of 305 cases were correctly diagnosed. In the pilot validation study, three investigators made a correct diagnosis in all cases using the decision tree. Conclusion Regardless of the morphology of astrocytic tau lesions, semi-quantitative tau pathology scores in select brain regions are sufficient to distinguish PSP and CBD. The decision tree simplifies neuropathologic differential diagnosis of PSP and CBD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据